Cargando…
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491170/ https://www.ncbi.nlm.nih.gov/pubmed/34609601 http://dx.doi.org/10.1007/s00415-021-10818-w |
| _version_ | 1784578688360120320 |
|---|---|
| author | Eisenhut, Katharina Buchka, Stefan Eichhorn, Peter Meier, Harald Albashiti, Fady Mansmann, Ulrich Schlüter, Miriam Havla, Joachim Kümpfel, Tania |
| author_facet | Eisenhut, Katharina Buchka, Stefan Eichhorn, Peter Meier, Harald Albashiti, Fady Mansmann, Ulrich Schlüter, Miriam Havla, Joachim Kümpfel, Tania |
| author_sort | Eisenhut, Katharina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8491170 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84911702021-10-05 SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort Eisenhut, Katharina Buchka, Stefan Eichhorn, Peter Meier, Harald Albashiti, Fady Mansmann, Ulrich Schlüter, Miriam Havla, Joachim Kümpfel, Tania J Neurol Letter to the Editors Springer Berlin Heidelberg 2021-10-05 2022 /pmc/articles/PMC8491170/ /pubmed/34609601 http://dx.doi.org/10.1007/s00415-021-10818-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editors Eisenhut, Katharina Buchka, Stefan Eichhorn, Peter Meier, Harald Albashiti, Fady Mansmann, Ulrich Schlüter, Miriam Havla, Joachim Kümpfel, Tania SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| title | SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| title_full | SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| title_fullStr | SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| title_full_unstemmed | SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| title_short | SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| title_sort | sars-cov-2 antibody seroprevalence in a large neuroimmunological patient cohort |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491170/ https://www.ncbi.nlm.nih.gov/pubmed/34609601 http://dx.doi.org/10.1007/s00415-021-10818-w |
| work_keys_str_mv | AT eisenhutkatharina sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT buchkastefan sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT eichhornpeter sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT meierharald sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT albashitifady sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT mansmannulrich sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT schlutermiriam sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT havlajoachim sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort AT kumpfeltania sarscov2antibodyseroprevalenceinalargeneuroimmunologicalpatientcohort |